HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.

AbstractBACKGROUND:
Soft tissue sarcomas are a heterogeneous group of malignant tumors. Standard treatment for soft tissue sarcoma of the extremity is surgical excision and adjuvant therapy; however, the role of neoadjuvant chemotherapy is controversial.
QUESTIONS/PURPOSES:
We sought to (1) define the histologic characteristics of the pseudocapsule in soft tissue sarcomas; (2) compare the appearance of this structure in chemotherapy-treated versus untreated soft tissue sarcomas; and (3) evaluate the effect of chemotherapy on the presence and viability of tumor cells at the host-sarcoma interface.
METHODS:
Twenty-eight patients with biopsy-proven, deep, high-grade extremity soft tissue sarcomas greater than 5 cm (AJCC stage III) treated with chemotherapy and surgical excision were compared histologically with 47 matched control subjects treated with surgery alone.
RESULTS:
A pseudocapsule was identifiable in the majority of tumors and consisted of two identifiable layers, each with specific histological characteristics suggesting the biologic processes occurring in these layers are different. The pseudocapsule was more frequently observed in the group treated with chemotherapy and it was more frequently continuous, thicker, and better developed in this group. Chemotherapy decreased the number of tumors with malignant cells identified within and beyond the pseudocapsule.
CONCLUSIONS:
Neoadjuvant chemotherapy contributed to the development of a pseudocapsule and decreased the number of tumors with malignant cells identified within and beyond the pseudocapsule.
CLINICAL RELEVANCE:
These findings may provide a histological explanation for the clinical effect of chemotherapy in soft tissue sarcoma.
LEVEL OF EVIDENCE:
Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
AuthorsPatrick W O'Donnell, J Carlos Manivel, Edward Y Cheng, Denis R Clohisy
JournalClinical orthopaedics and related research (Clin Orthop Relat Res) Vol. 472 Issue 3 Pg. 849-55 (Mar 2014) ISSN: 1528-1132 [Electronic] United States
PMID23640206 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Doxorubicin
  • Ifosfamide
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Biopsy
  • Cell Survival (drug effects)
  • Chemotherapy, Adjuvant
  • Doxorubicin (administration & dosage)
  • Female
  • Humans
  • Ifosfamide (administration & dosage)
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Grading
  • Neoplasm Staging
  • Retrospective Studies
  • Sarcoma (drug therapy, pathology, surgery)
  • Soft Tissue Neoplasms (drug therapy, pathology, surgery)
  • Treatment Outcome
  • Tumor Burden
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: